Group K Diagnostics

Group K Diagnostics Overview

Founded 2016
Status Private
Employees 15
Latest Deal Type Early Stage VC
Latest Deal Amount $959K
Latest Deal Amount
Investors 8

Group K Diagnostics General Information


Developer of a single-platform diagnostic test that can be done at the point of care using a variety of traditional and novel clinical analysis. The company's platform offers 20-minute point-of-care with the potential for more than 40 blood tests, leverages paper or wax-based microfluidics technology to reduce cost and time of testing, enabling users to improve patient care while easing provider burden.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Primary Office
  • 1015 Chestnut Street
  • Suite 1015
  • Philadelphia, PA 19107
  • United States
+1 (267) 000-0000

Group K Diagnostics Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Group K Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC 26-Aug-2019 $959K 00.000 Completed Clinical Trials - General
6. Early Stage VC (Series A) 29-Nov-2018 00.000 00.00 Completed Clinical Trials - General
5. Seed Round 01-Nov-2017 00000 00000 Completed Clinical Trials - General
4. Accelerator/Incubator 27-Mar-2017 Completed Pre-Clinical Trials
3. Accelerator/Incubator 20-Mar-2017 Completed Pre-Clinical Trials
2. Accelerator/Incubator 01-Jan-2017 Completed Startup
1. Grant 02-Dec-2016 Completed Startup

Group K Diagnostics Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Diagnostics For All Corporation Salem, MA 0000000000
000000 Formerly VC-backed Union City, CA 000 000.00 000000&0 000.00
000000 00000 00 00 Corporate Backed or Acquired Princeton, NJ 0000 000000&0
0. 00000000-00 000 Corporation Basel, Switzerland 00000 00000 00000000000

Group K Diagnostics Executive Team (4)

Name Title Board Seat Contact Info
Brianna Wronko Co-Founder, Chief Executive Officer & Chairwoman

3 Former Executives

Group K Diagnostics Board Members (3)

To view Group K Diagnostics‘s full board member team, request access »
Name Representing Role Since
Brianna Wronko Group K Diagnostics Co-Founder, Chief Executive Officer & Chairwoman 000 0000
Paul Farr Group K Diagnostics Board Member 000 0000

1 Former Board Member

Group K Diagnostics Investors (8)

To view Group K Diagnostics‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BioAdvance Venture Capital Minority 000 0000 000000 0
Lehigh Valley Angel Investors Angel Group Minority 000 0000 000000 0
University of Pennsylvania Endowment Limited Partner Minority 000 0000 000000 0
DreamIt Ventures Accelerator/Incubator Minority 000 0000 000000 0
Wharton Venture Initiation Program Accelerator/Incubator Minority 000 0000 000000 0

Ready to get started?

Request a free trial